Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Pentraxin-3 has therapeutic activity in mice with P. aeruginosa lung infection

Nov. 9, 2010

Array Biopharma discloses promising preclinical data on ARRY-575

Nov. 9, 2010

MEDI-8662 and CAIV-T flu vaccines demonstrate comparable safety/immunogenicity in phase III trial

Nov. 9, 2010

Ganglioside vaccine NeuGcGM3/VSSP shows promise in melanoma

Nov. 9, 2010

Several phase II/III trials show safety and efficacy of fingolimod in relapsing-remitting MS

Nov. 9, 2010

AN-3661 is efficacious against Plasmodium infections in mice

Nov. 8, 2010

Quadrivalent Fluzone QIV is as safe and immunogenic as trivalent flu vaccines

Nov. 8, 2010

Intranasal GI.1 norovirus virus-like particle vaccine is safe and efficacious in healthy volunteers

Nov. 8, 2010

Dengue virus therapy AVI-6006 shows promise in animal models

Nov. 8, 2010

Interim phase I/II data presented on dovitinib in RCC

Nov. 5, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...
Circulating sncRNA transcriptome in diabetic kidney disease and SGLT2 inhibitor treatment
BioWorld Science
Small noncoding RNAs (sncRNAs), including miRNAs, piRNAs and snoRNAs, can provide further biological insights into the mechanisms of chronic kidney disease (CKD)...